Entera Bio Ltd. (ENTX:NASDAQ) closed at $3.02 on November 3, 2026, down 2.43% on the day. The stock trades 28.2% below its 52-week high of $4.20 and 231.3% above its 52-week low of $0.910. Over the past year, it gained 8.8%. Entera Bio Ltd. is part of the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)).
In 252 trading sessions since October 31, 2025, ENTX closed higher on 108 days (43%). Its best day was July 27, 2026 (+91.22%) and its worst was July 28, 2026 (-16.84%). The stock moved 10% or more in a single session 22 times. It opened at least 5% above the previous day's high 1 time.
Entera Bio Ltd is a biotechnology company specializing in the oral delivery of large molecules and biologics. It conducts clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics.
Find more stocks like ENTX with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.